TREM2 and Alzheimer disease: demonstrated that TREM2-deficient mice exhibited reduced Iba1+ cells, neuroinflammation and Aβ deposition at 4 months of age, indicating that TREM2 plays detrimental role at the early stages of AD and beneficial role at late stages (96, 101).